Atara Biotherapeutics Stock Price on November 20, 2024
| ATRA Stock | USD 10.50 0.01 0.1% |
Below is the normalized historical share price chart for Atara Biotherapeutics extending back to October 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Atara Biotherapeutics stands at 10.50, as last reported on the 17th of December 2024, with the highest price reaching 10.50 and the lowest price hitting 10.50 during the day.
If you're considering investing in Atara Stock, it is important to understand the factors that can impact its price. Atara Biotherapeutics appears to be slightly risky, given 3 months investment horizon. Atara Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1% return per unit of standard deviation over the last 3 months. By analyzing Atara Biotherapeutics' technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please makes use of Atara Biotherapeutics' risk adjusted performance of 0.0438, and Mean Deviation of 4.32 to double-check if our risk estimates are consistent with your expectations.
At present, Atara Biotherapeutics' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 302.7 M, whereas Total Stockholder Equity is projected to grow to (94.3 M). . As of December 17, 2024, Price To Sales Ratio is expected to decline to 6.02. In addition to that, Price Earnings Ratio is expected to decline to -0.21. Atara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of October 2014 | 200 Day MA 11.9284 | 50 Day MA 10.4515 | Beta 0.495 |
Atara |
Sharpe Ratio = 0.1048
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.02 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Atara Biotherapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atara Biotherapeutics by adding it to a well-diversified portfolio.
Price Book 1.9674 | Enterprise Value Ebitda (0.35) | Price Sales 0.9537 | Shares Float 4.1 M | Wall Street Target Price 14.75 |
Atara Biotherapeutics Main Headline on 20th of November 2024
Atara biotherapeutics CFO Eric Hyllengren sells 15,274 in st... by investing.com
Atara biotherapeutics CFO Eric Hyllengren sells 15,274 in stock
Atara Biotherapeutics Valuation on November 20, 2024
It is possible to determine the worth of Atara Biotherapeutics on a given historical date. On November 20, 2024 Atara was worth 11.0 at the beginning of the trading date compared to the closed value of 10.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Atara Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Atara Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atara Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Atara Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 11.15 | 11.70 | 10.52 | 10.99 | 138,162 | |
11/20/2024 | 11.00 | 11.15 | 10.32 | 10.68 | 108,461 |
| 10.73 | 10.73 | 10.03 | 10.61 | 79,677 |
| Backtest Atara Biotherapeutics | | | Atara Biotherapeutics History | | | Atara Biotherapeutics Valuation | Previous | Next |
Atara Biotherapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 Atara Biotherapeutics was traded for 10.61 at the closing time. The top price for the day was 10.73 and the lowest listed price was 10.03 . The trading volume for the day was 79.7 K. The trading history from November 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.66% . The overall trading delta against the current closing price is 12.27% . |
Atara Biotherapeutics Fundamentals Correlations and Trends
By evaluating Atara Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Atara Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Atara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Atara Biotherapeutics Stock history
Atara Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atara Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atara Biotherapeutics stock prices may prove useful in developing a viable investing in Atara Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.2 M | 4 M | |
| Net Loss | -205.5 M | -215.7 M |
Atara Biotherapeutics Stock Technical Analysis
Atara Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Atara Biotherapeutics Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Atara Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Atara Biotherapeutics December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Atara Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Atara Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Atara Biotherapeutics stock market strength indicators, traders can identify Atara Biotherapeutics entry and exit signals to maximize returns
Atara Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Atara Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Atara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0438 | |||
| Jensen Alpha | 0.1903 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0409 | |||
| Treynor Ratio | 0.222 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |